EXPENEUTRAL

P/E Ratio

21.3x

Updated 248h ago

Sector Performance

42th percentile

EXPE

21.3x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current price-to-earnings (P/E) ratio of 21.3x means investors are paying $21.30 for every $1.00 of the company's earnings — a measure of how expensive or cheap the stock is relative to its profitability.

Compared to the sector median of 23.7x, EXPE's P/E is lower, placing it at the 44th percentile among peers, meaning it is cheaper than a majority of the sector. The year-over-year change is not available, but the quarter-over-quarter change shows a decline of -3.6%, indicating the valuation has compressed slightly from 22.1x in the prior quarter. A P/E below the sector median combined with a recent decline could suggest a potential value opportunity if earnings are stable, but it also may reflect falling investor expectations or weaker earnings growth. The limited trend data (only two quarterly points) prevents a strong directional conclusion, so the risk-reward balance remains moderate. This metric supports the overall NEUTRAL

Frequently Asked Questions

What does the P/E Ratio tell investors about EXPE?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are EXPE's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master EXPE's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full EXPE research report

Free account — no credit card

EXPE

21.3x

Sector Median

24.7x

Sector Avg

36.0x

How EXPE's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.